ipriflavone has been researched along with Acute Lymphoid Leukemia in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pagano, L | 1 |
| Teofili, L | 1 |
| Mele, L | 1 |
| Piantelli, M | 1 |
| Ranelletti, FO | 1 |
| Equitani, F | 1 |
| Larocca, LM | 1 |
| Leone, G | 1 |
1 trial available for ipriflavone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemias.
Topics: Administration, Oral; Aged; Drug Resistance, Neoplasm; Female; Humans; Isoflavones; Leukemia, Myeloi | 1999 |